期刊文献+

重组人甲状旁腺素(1-34)对角质形成细胞分泌IL-6和IL-8的影响 被引量:5

Effect of Recombinant Human Parathormone(1-34) on the Excretion of IL-6 and IL-8 by Keratinocyte
下载PDF
导出
摘要 目的研究人甲状旁腺素(PTH)(1-34)对角质形成细胞分泌IL-6和IL-8的影响,探讨其治疗银屑病的分子机理。方法体外培养人角质形成细胞株(HaCaT),研究中设空白对照组、骨化三醇组、骨化三醇和PTH(1-34)联合组以及1.0×10-7mol/L~1.0×10-10mol/L4个不同剂量的PTH(1-34)给药组。48h后收集上清液,用酶联免疫吸附法(ELISA)检测HaCaT细胞分泌至培养液中IL-6和IL-8的含量。结果在1.0×10-7mol/L~1.010-10mol/L四个梯度浓度PTH(1-34)及联合骨化三醇处理48h后,HaCaT细胞分泌IL-6量和空白对照组、骨化三醇组比较,差异无统计学意义,而IL-8的分泌量明显降低(P<0.05),且1.0×10-7mol/LPTH(1-34)处理组IL-8分泌量明显低于其他各组。结论PTH(1-34)治疗银屑病的作用机制可能部分通过调节IL-8的表达和分泌来实现。 Objective To investigate the effect of recombinant human parathormone(1-34) on the excretion of IL-6 and IL-8 by keratinocyte and the molecular mechanism underlying its therapeutic effect on psoriasis. Methods Human keratinoeyte was cultured in vitro for investigation. Cultured cells were divided into 7 groups : ( 1 ) control group ; ( 2 ) ealeitriol group ; ( 3 ) calcitriol + PTH(1-34) group; (4)four PTH(1-34) groups with different PTH(1-34) dosages ranging from 10^-7mol/L to 10^-10mol/L. Supernatant was collected 48h after treatment, and ELISA was used to detect the expression level of IL-6 and IL-8. Results The amount of IL-6 in four PTH ( 1-34 ) groups or caleitriol + PTH (1-34) group was of no significantly different that of comparing with control or caleitriol group. However, the amount of IL-8 in four PTH(1-34) groups and caleitriol + PTH(1-34) group was significantly lower than that of control or ealcitriol group ( P 〈 0.05 ). Conclusion The therapeutic effect of PTH ( 1-34 ) on psoriasis may partly through modulating the expression and excretion of IL-8.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2009年第6期341-343,共3页 The Chinese Journal of Dermatovenereology
关键词 银屑病 角质形成细胞 PTH(1—34) IL-6 IL-8 psoriasis HaCaT keratinocyte PTH(1-34) IL-6 IL-8
  • 相关文献

参考文献8

  • 1ANDREASSEN T T, WILLICK G E, MORLEY P, et al. Treatment with parathyroid hormone hPTH ( 1-34 ), hPTH ( 1-31 ) , and monocyclic hPTH (1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase [ J ]. Calcif Tissue Int, 2004,74 (4) : 351 - 356.
  • 2REGANA M S, EZQUERRA G M, MILLET P U. Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis [ J ]. Acta Derm Venercol,2005,85 (5) : 420 - 423.
  • 3KIS K, BODAI L, POLYANKA H, et al. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes[ J]. Int Immunopharmacol,2006,6 ( 3 ) : 358 - 368.
  • 4ERRAZAHI A, BOUIZAR Z, LIEBERHERR M, et al. Functional type I PTH/PTHrP receptor in freshly isolated newborn rat keratinocytes: identification by RT-PCR and immunohistochemistry [ J ]. J Bone Miner Res,2003,18(4) :737 -750.
  • 5HOLICK M F, RAY S, CHEN T C,et al. A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice[J]. Proc Natl Acad Sei U S A, 1994,91(17) :8014 -8016.
  • 6HOLICK M F, CHIMEH F N, RAY S. Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial[J]. Br J Dermatol,2003,149(2) :370 -376.
  • 7WHITFIELD J F. Taming psoriatic keratinocytes-PTHs' uses go up another notch[J]. J Cell Biochem,2004,3(2) :251 -256.
  • 8ERRAZAHI A, LIEBERHERR M, BOUIZAR Z, et al. PTH-1R responses to PTHrP and regulation by vitamin D in keratinocytes and adjacent fibroblasts [ J ]. J Steroid Biochem Mol Biol, 2004,89 - 90 ( 1 - 5 ) :381 - 385.

同被引文献83

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部